Health Plan & Provider Report Index Summary

GAINSHARING

– Hospitals, medical device makers express concerns in letter to CMS, 212

GENERIC DRUGS

– BCBS, consumer use expansion campaign, survey, 440
– Biogenerics, PBM specialty tiering cost shifting effect necessitates approval pathway, report, 319
– FEHBP, most enrollees pay $55 monthly for specialty medications without alternatives, GAO report, 670
– Part D, brand name access also increased, report, 45
– Prescription spending, increased generic use offset brand-name price increases, report, 598
– Upstate N.Y., use cut $369 million in costs, 223

GENETIC INFORMATION NONDISCRIMINATION ACT (GINA)

– Implementation

– – CMS, regulatory agenda, 589; interim final rules released, 1152
– – EBSA, regulatory agenda, 589; interim final rules released, 1152
– – EEOC releases proposed rules, 256; final rules expected May 21, 589
– – IRS, regulatory agenda, 589; interim final and proposed rules released, 1152

– Medigap, CMS to use Natl. Ass'n of Ins. Comm'n model for regulations, 486

GENETICS AND BIOTECHNOLOGY

– Biogenerics

See GENERIC DRUGS

GIFTS

– Hospitals, Mass. network implements rules restricting drug and device company ties, 439
– Iowa providers, senate bill to ban passed, 386

GINA

See GENETIC INFORMATION NONDISCRIMINATION ACT (GINA)

GRANTS

– Electronic health records, state agency provides for Los Angeles County, 223